close

ZOLL Medical Corporation, together with its subsidiaries, designs, manufactures, markets, and sells non-invasive resuscitation devices and related software solutions in the United States and internationally. The company's products include pacing, defibrillation, circulation, ventilation, and fluid resuscitation devices that enable clinicians, emergency medical services (EMS) professionals, and lay rescuers resuscitate sudden cardiac arrest or trauma victims. Its resuscitation line of products include professional defibrillators, which include the M Series, E Series, R Series, and automated external defibrillators (AED) Pro with manual defibrillation capability; AED products for use by trained rescuers, which include the AED Pro and the AED Plus; disposable electrodes used with ZOLL's line of defibrillators; the AutoPulse automated chest compression systems, used to automate the process of delivering chest compressions; documentation and information management products, including RescueNet for EMS and fire personnel and CodeNet for hospitals; device and technology designed for endovascular hypothermia; and the ZOLL Infuser for fluid replacement. The company also offers various single-patient-use proprietary disposable electrodes for use with ZOLL's line of defibrillators and AEDs. It markets its products primarily to hospitals, EMS, and public safety markets through sales and managerial staff comprising direct representatives and their managers, distribution managers, special account representatives, distributors, and manufacturer's representatives. ZOLL Medical Corporation was founded in 1980 and is headquartered in Chelmsford, Massachusetts.

(login to add this stock to your watchlist or favorites)

Key Statistics

Closing Price	92.73
Volume	(mio) 1.35
Volume Avg	375871
52 Week High	93.02
52 Week Low	33.84
PE	62.02
PE (group average)	39
EPS Year	1.50
EPS change Q/Q	55.56%
EPS change Q/Q Yr ago	64.71%
EPS change Q/Q next Q est	-47.17%
EPS change Y/Y	-52.34%
REV change Q/Q	8.22%
REV change Q/Q Yr ago	14.38%
EPS next Q est	0.53
EPS next Y est	2.66
Divident Annual	0.00
Dividend Yield	0%